In addition, ALK fusion proteins have been reported in nonelastic ALCL, inflammatory myofibrosarcoma (IMT), diffuse large B-cell lymphoma (DLBCL), and non-small cell lung cancer (NSCLC) [64]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.